Debra Saltz, long tenured Annapolis, MD area Attorney has entered into an agreement with Albers & Associates, a Maryland Law Firm. Ms. Saltz, the Managing Member of her Firm states that "We are ...

Students from around the world saw their space-themed works of pen, paint, and poetry floating in the cupola of the International Space Station (ISS) as part of a contest to spark student interest in ...

Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

A treatment that could potentially slow the progression of amyotrophic lateral sclerosis (ALS) is being studied at the Montreal Neurological Institute-Hospital. Dr. Olivier Blanchard and his team want ...

A man who was left unable to walk or talk by a neurological disorder has called for greater understanding of his condition after he was told to "get moving" by a GP. Liam Virgo, 22, was 13 when he ...

RBC Capital analyst Shagun Singh said the deal fit strategically into J&J's neurological drugs division, an important area for the company. Sales of J&J's neurological drugs But at least one ...

(Reuters) - Johnson & Johnson said on Monday it would buy neurological drug maker Intra-Cellular Therapies for $14.6 billion, its biggest deal in more than two years, boosting its presence in the ...

as well as SAGE-324 in essential tremor and other neurological disorders. The blockbuster deal featured an upfront payment of $875 million from Biogen and a $650 million equity investment in Sage.

Tenvie Therapeutics has unveiled with $200 million and the goal of transforming the neurological treatment landscape, nabbing several programs—and an executive—from Denali Therapeutics.